A Shot in the Arm for Philosophy of Biology: How to Treat Infectious Diseases

被引:0
|
作者
Bradley, Constance [1 ]
机构
[1] Phoenix Inst Oriental Med & Acupuncture, Oriental Med, Phoenix, AZ 85023 USA
来源
SAGE OPEN | 2014年 / 4卷 / 01期
关键词
infectious disease; epidemiology; evolutionary biology; natural kinds; philosophy of science;
D O I
10.1177/2158244014529134
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
This article analyzes infectious diseases (IDs) within a philosophy of biology framework to locate factors that play a role in the development of a successful account of IDs. One way to handle the analysis of kinds in biology is through a traditional essentialist approach whereby biological entities are construed as natural kinds with essences. Approaching IDs in this way is unworkable, however, because it is difficult to find essences that occur in all and only IDs. Rather than engaging IDs from this perspective, my analysis of the nature of IDs more appropriately falls under the rubric of philosophy of biology whereby I treat particular IDs as products of evolution with a unique relationship to the biological hierarchy. This approach is what I refer to as an evolutionary perspective of IDs because it emphasizes that the constituent mechanisms and processes of ID are sensitive to evolutionary pressures. Such an approach is useful because it allows us to sidestep difficulties pervasive traditional kind essentialist accounts of ID. To begin, I analyze two contemporary methods for analyzing kinds in biology-Richard Boyd's Homeostatic Property Cluster (HPC) kind approach and Paul Griffiths' treatment of kinds with historical essences. I discuss both approaches and identify the limitations of each that prevent a successful account of IDs. I then analyze how elements of each account can be revised into a successful philosophy of biology approach to IDs. The article is concluded with a brief discussion of the benefit of incorporating an evolutionary perspective into the analysis of IDs and outlines future projects that result from approaching IDs from an evolutionary perspective.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] CRISPR-Cas Biology and Its Application to Infectious Diseases
    Strich, Jeffrey R.
    Chertow, Daniel S.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (04)
  • [42] Symposium on Population Biology, Evolution, and Control of Infectious Diseases - Introduction
    Stephens, DS
    Levin, B
    Halloran, ME
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 315 (02): : 63 - 63
  • [43] Can "presumed consent" justify the duty to treat infectious diseases? An analysis
    Murat Civaner
    Berna Arda
    BMC Infectious Diseases, 8
  • [44] Can "presumed consent" justify the duty to treat infectious diseases? An analysis
    Civaner, Murat
    Arda, Berna
    BMC INFECTIOUS DISEASES, 2008, 8 (1)
  • [45] The use of AAV vectors to express antibodies to prevent and/or treat infectious diseases
    Wilson, James M.
    HUMAN GENE THERAPY, 2014, 25 (11) : A10 - A10
  • [46] The eradication of infectious viral diseases endangered by advances in synthetic biology
    Tournier, Jean-Nicolas
    M S-MEDECINE SCIENCES, 2019, 35 (02): : 181 - 185
  • [47] RNA Viruses: A Case Study of the Biology of Emerging Infectious Diseases
    Woolhouse, Mark E. J.
    Adair, Kyle
    Brierley, Liam
    MICROBIOLOGY SPECTRUM, 2013, 1 (01): : 83 - 97
  • [48] MOLECULAR-BIOLOGY IN HEPATIC, GASTROINTESTINAL AND INFECTIOUS-DISEASES
    WALTER, E
    LUTHY, R
    INTERNIST, 1994, 35 (02): : 155 - 162
  • [49] Bacteriophage-based synthetic biology for the study of infectious diseases
    Citorik, Robert J.
    Mimee, Mark
    Lu, Timothy K.
    CURRENT OPINION IN MICROBIOLOGY, 2014, 19 : 59 - 69
  • [50] Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases
    DiMasi, Joseph A.
    Florez, Maria, I
    Stergiopoulos, Stella
    Pena, Yaritza
    Smith, Zachary
    Wilkinson, Michael
    Getz, Kenneth A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (02) : 324 - 332